Cortical Blindness after Contrast-Enhanced CT: Complication in a Patient with Diabetes Insipidus
Hans-Joachim Mentzela,
Jörg Blumeb,
Ansgar Malicha,
Clemens Fitzeka,
Jürgen R. Reichenbacha and
Werner A. Kaisera
a Institute of Diagnostic and Interventional Radiology, University of Jena, Jena, Germany
b Department of Pediatrics, University of Jena, Jena, Germany

View larger version (151K):
[in a new window]
|
FIG 1. MR imaging revealing no abnormalities in the occipital lobe, no hyperintensities on T2-weighted or FLAIR sequences, no infarction with reduced diffusion, and no vessel occlusion.
A, Axial FLAIR image.
B, Time-of-flight angiography (maximum intensity projection).
C, Axial T2-weighted image.
D, Diffusion-weighted image (b = 1000).
| |

View larger version (87K):
[in a new window]
|
FIG 2. No contrast-enhancing effect in the occipital lobe after administration of gadopentetate dimeglumine (Gd-DTPA).
A, T1-weighted native spin-echo sequence.
B, T1-weighted spin-echo sequence after administration of 0.1 mmol/kg GdDTPA.
| |